Cigna Corporation (NYSE:CI) has a beta value of 0.9 and has seen 1,683,062 shares traded in the last trading session. The company, currently valued at $90.15 Billion, closed the last trade at $259.5 per share which meant it gained $7.45 on the day or 2.96% during that session. The CI stock price is 0% off its 52-week high price of $259.51 and 38.79% above the 52-week low of $158.84. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.75 Million shares traded. The 3-month trading volume is 1.94 Million shares.
The consensus among analysts is that Cigna Corporation (CI) is a Buy stock at the moment, with a recommendation rating of 1.8. None of the analysts rate the stock as a Sell, while 1 rate it as Overweight. 2 out of 24 have rated it as a Hold, with 21 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $4.38.
Cigna Corporation (NYSE:CI) trade information
Wall Street analysts have a consensus price target for the stock at $268.39, which means that the shares’ value could jump 3.43% from current levels. The projected low price target is $230 while the price target rests at a high of $300. In that case, then, we find that the current price level is +15.61% off the targeted high while a plunge would see the stock lose -11.37% from current levels.
Cigna Corporation (CI) estimates and forecasts
Figures show that Cigna Corporation shares have underperformed across the wider relevant industry. The company’s shares have gained +55.42% over the past 6 months, with this year growth rate of 10.03%, compared to 12.9% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are -6.6% and -14.1% for the next quarter. Revenue growth from the last financial year stood is estimated to be +3.6%.
14 analysts offering their estimates for the company have set an average revenue estimate of $40.24 Billion for the current quarter. 14 have an estimated revenue figure of $41.13 Billion for the next quarter concluding in June 01, 2021. Year-ago sales stood $38.39 Billion and $37.75 Billion respectively for this quarter and the next, and analysts expect sales will grow by 4.8% for the current quarter and 9% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +23.4% over the past 5 years. Earnings growth for 2021 is a modest +70.9% while over the next 5 years, the company’s earnings are expected to increase by 10.35%.
Cigna Corporation is expected to release its next earnings report between May 07 and May 07 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 4 at a share yield of 1.61%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 0.04%.
Cigna Corporation (NYSE:CI)’s Major holders
Insiders own 1.45% of the company shares, while shares held by institutions stand at 93.27% with a share float percentage of 94.64%. Investors are also buoyed by the number of investors in a company, with Cigna Corporation having a total of 1628 institutions that hold shares in the company. The top two institutional holders are Price (T.Rowe) Associates Inc with over 29.88 Million shares worth more than $6.22 Billion. As of December 30, 2020, Price (T.Rowe) Associates Inc held 8.6% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 27.97 Million shares as of December 30, 2020. The firm’s total holdings are worth over $5.82 Billion and represent 8.05% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Dodge & Cox Stock Fund. As of December 30, 2020, the former fund manager holds about 2.93% shares in the company for having 10185200 shares of worth $2.12 Billion while later fund manager owns 9.73 Million shares of worth $2.03 Billion as of December 30, 2020, which makes it owner of about 2.8% of company’s outstanding stock.